# Clinical Trial With Aconite Pain Oil in Oncology Patients Under Chemotherapy to Prevent CIPN Grade-II, to Reduce Symptoms and to Improve the Quality of Life of Patients With CIPN

> **NCT06186479** · PHASE3 · RECRUITING · sponsor: **WALA Heilmittel GmbH** · enrollment: 350 (estimated)

## Conditions studied

- Chemotherapy-induced Polyneuropathy

## Interventions

- **DRUG:** Aconite pain oil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06186479
- **Lead sponsor:** WALA Heilmittel GmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-13
- **Primary completion:** 2027-08-01
- **Final completion:** 2027-08-01
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2025-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06186479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06186479, "Clinical Trial With Aconite Pain Oil in Oncology Patients Under Chemotherapy to Prevent CIPN Grade-II, to Reduce Symptoms and to Improve the Quality of Life of Patients With CIPN". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06186479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*